Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Histone H3 and H4 are highly conserved core proteins that associate to form a (H3-H4)2 tetramer, which constitutes the central scaffold of the nucleosome around which eukaryotic DNA is wrapped (Source 1.1.5, 1.2.4). These proteins play a fundamental role in chromatin architecture, DNA packaging, and the epigenetic regulation of gene expression through various post-translational modifications on their N-terminal tails (Source 1.1.2, 1.4.3). Recent research has also revealed that the H3-H4 tetramer possesses intrinsic oxidoreductase activity, facilitating the reduction of copper ions necessary for mitochondrial respiration and cellular metabolism (Source 1.2.2). In pathological states such as sepsis and acute respiratory distress syndrome (ARDS), histones are released into the extracellular space where they act as potent damage-associated molecular patterns (DAMPs), causing significant endothelial injury, promoting thrombosis, and triggering organ dysfunction (Source 1.5.1, 1.5.3). Therapeutic strategies targeting Histone H3/H4 include the use of neutralizing antibodies (e.g., anti-H4), polyanionic compounds like heparin, and activated protein C to mitigate extracellular toxicity, as well as experimental small molecules designed to disrupt their interactions with histone chaperones in cancer (Source 1.1.1, 1.5.3). Additionally, specific "oncohistone" mutations, such as H3K27M, are critical drivers in certain pediatric cancers, making them important diagnostic and prognostic biomarkers (Source 1.2.1, 1.4.1).
Neutralization of extracellular histone toxicity; Proteolytic cleavage of histones; Inhibition of histone-chaperone interactions; Modulation of copper homeostasis via oxidoreductase activity.
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Histone H3-H4 complex (H3/H4).